BerGenBio completes IPO

On April 6, cancer company BerGenBio ASA (OSE:BGBIO) raised NOK400 million ($46.6 million) through the sale of 16 million shares at NOK25 in an IPO underwritten by ABG Sundal Collier, Arctic Securiti...